Where We Work
See our interactive map
IntraHealth has demonstrated the potential for significant improvements in prompt and effective malaria treatment at the community level in Senegal, with a recent evaluation showing the proportion of children going to local health facilities for care increasing five-fold in three years.
IntraHealth implemented the Pfizer Mobilize Against Malaria Program (MAM) in the Tambacounda region of Senegal from 2007-2011. The program, as part of Pfizer’s signature philanthropic investment in malaria, involved local partners and stakeholders and a global evaluation team from the London School of Hygiene & Tropical Medicine (LSHTM).
Through MAM Senegal, IntraHealth rehabilitated community-based ‘health huts’ in three districts of Tambacounda, a geographically challenging region with a highly dispersed population. Frequent monitoring data gathered by IntraHealth, in collaboration with the LSHTM, enabled the project to develop responsive and innovative approaches to implementation.
LSHTM’s research findings demonstrate that many communities invested their time, commitment, and resources to build and maintain their own local sources of basic health care.
The proportion of children under five with a fever who sought treatment outside the home has remained at around 60% since 2008. However:
The impact of the project’s day-to-day work was documented in a short video produced by the LSHTM. The film, which demonstrates key program approaches and achievements, was launched in May 2012 at a dissemination meeting in Dakar and was viewed by stakeholders, the National Malaria Control Program staff, representatives from other nongovernmental organizations, implementers, and donors.